CS
Champions Oncology, Inc.
CSBR · NASDAQ
$5.10 +2.11% (+$0.11)
1M +3.03%
Market Cap $70.8M
P/E Ratio -
Div. Yield -
ROE 29.56%
Bulios Fair Price
$7.51
47.4% upside
Trenutna cena
$5.1
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica CSBR trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
22 /100
Expensive EV/EBITDA 157.41x
P/S 1.19x
P/B 17.97x
Growth
0 /100
Declining Book val. growth 5.29%
EPS growth N/A
Rev. growth N/A
Profitability
19 /100
Weak Gross margin 48.00%
Net margin 1.98%
Op. margin 1.92%
Quality
15 /100
Poor ROIC 16.64%
ROE 29.56%
ROA 4.35%
Debt
67 /100
Low Debt/Equity 1.17x
Current ratio 0.96x
Net debt/EBITDA -0.61x
Stability
14 /100
Unstable Beta 0.41x
Rev. volatility 60.52%
EPS volatility 146.41%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o CSBR
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Robert Brainin
Employees
214
Headquarters
Hackensack